#USA #MedTech #Veeva Systems #Barcelona #Quality Management

Embracing Change in MedTech: Quality Management Priorities

In the evolving landscape of medical technology, a recent revelation has emerged from the Veeva MedTech Postmarket Quality Benchmark Report 2025. This study indicates that 88% of interviewed MedTech companies are prioritizing the modernization of their post-market quality management within the next three years. Companies recognize that this shift is essential for improving compliance and driving innovation across their operations.

The Push for Quality Management Modernization

The findings illustrate a significant trend in the MedTech sector where there’s a growing focus on automation, connectivity, and efficient reporting systems. These components are crucial for fostering a proactive quality management framework that ensures safety throughout the product lifecycle.

Despite this progressive outlook, it is concerning that 68% of respondents still rely on outdated manual processes, which include a mix of paper-based and electronic systems. Relying on such antiquated methods can lead to delays in addressing product issues, resulting in a backlog of complaints. Companies that fail to respond swiftly to safety concerns not only risk regulatory non-compliance but also jeopardize consumer trust and their brand image.

Strategies for Streamlining Quality Processes

The report elaborates on potential strategies that MedTech firms might implement to streamline their quality processes, aiming for enhanced proactive management and operational efficiency:

Focus on Proactive Risk Management

Key drivers identified for enhancing quality include implementing proactive and risk-based quality management strategies (38% prioritization) and scaling processes to facilitate growth in response to market dynamics (26%). By realigning to proactive methodologies, companies can better manage risks, leading to higher standards in product quality.

Leveraging Technology

Over half of the surveyed companies are still entrenched in manual operational models. The majority (75%) acknowledge that advanced technologies could facilitate automation for shorter timelines and increased efficiency. Two-thirds (62%) also recognize the potential for integrating with other quality management systems, while 61% believe that enhanced reporting capabilities could support better data-driven decisions.

However, emerging technologies like generative AI, intelligent automation, and robotic process automation have seen minimal adoption, with less than 3% of firms incorporating these innovations effectively into their operations. The optimistic outlook remains as many identify significant opportunities to enhance timeliness and operational efficiency through these technologies.

Addressing Training Gaps

One alarming statistic from the survey reveals that only 19% of respondents feel their training programs are adequate to prepare post-market quality teams for future challenges. This gap points to an important area for improvement, suggesting a shift towards interactive learning approaches that provide employees with real-time updates and guidance crucial to their roles.

The Path Forward for MedTech Firms

Vishaka Rajaram, Senior Director of Quality Strategy at Veeva MedTech, remarked, “Despite initiatives aimed at standardizing and integrating quality processes, many surveyed firms remain constrained by legacy systems and manual workflows.”

To thrive in the increasingly complex landscape of healthcare, MedTech companies must align their strategic objectives with modern technological solutions, transitioning from reactive problem-solving to proactive risk prevention. By doing so, they can improve both efficiency and compliance, ultimately benefiting the quality of care available to patients.

In conclusion, the Veeva MedTech Postmarket Quality Benchmark Report 2025 surveyed over 100 leading MedTech firms to explore the progress, challenges, and opportunities within the realm of quality management in the medical technology and diagnostics field. For further insights, the complete benchmark report is available for review.